Cargando…
Immunogenicity of influenza A(H1N1)pdm09 vaccine and the associated factors on lowered immune response in patients with hepatitis C
Background Patients with underlying disease represent a high‐risk group for influenza‐associated complications and hospitalization. However, few studies investigated the immunogenicity of influenza vaccine in patients with liver disease. Objective To examine immunogenicity of influenza A(H1N1)pdm0...
Autores principales: | Ohfuji, Satoko, Fukushima, Wakaba, Tamori, Akihiro, Maeda, Kazuhiro, Maeda, Akiko, Hirota, Yoshio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5779820/ https://www.ncbi.nlm.nih.gov/pubmed/22897938 http://dx.doi.org/10.1111/j.1750-2659.2012.00424.x |
Ejemplares similares
-
Increased symptom severity but unchanged neuraminidase inhibitor effectiveness for A(H1N1)pdm09 in the 2010–2011 season: comparison with the previous season and with seasonal A(H3N2) and B
por: Kawai, Naoki, et al.
Publicado: (2012) -
Influenza surveillance from November 2008 to 2011; including pandemic influenza A(H1N1)pdm09 in Bhutan
por: Wangchuk, Sonam, et al.
Publicado: (2012) -
Hospitalizations from pandemic Influenza [A(H1N1)pdm09] infections among type 1 and 2 diabetes patients in Spain
por: Jiménez‐García, Rodrigo, et al.
Publicado: (2012) -
Antibody responses against influenza A(H1N1)pdm09 virus after sequential vaccination with pandemic and seasonal influenza vaccines in Finnish healthcare professionals
por: Strengell, Mari, et al.
Publicado: (2012) -
The dynamics of infection and the persistence of immunity to A(H1N1)pdm09 virus in Israel
por: Weil, Merav, et al.
Publicado: (2012)